Consumer price inflation reared its ugly head to start the year, dashing hopes for the Fed to lower borrowing costs anytime soon.

Morgan Stanley raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $70 and keeps an Equal Weight rating on the shares.

RBC Capital analyst Matthew Hedberg maintained a Hold rating on Teradata (TDC – Research Report) yesterday and set a price target of $29.00.

Anterix Inc. shares rise following the company's announcement of a strategic review process with Morgan Stanley. The review is in response to increasing demand for private wireless broadband solutions ...

Morgan Stanley (MS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Wall Street giants are eager to partner with crypto firms to capitalize on the U.S. crypto boom. Gemini, Circle, and Kraken ...

This was the stock's second consecutive day of losses.

The unemployment rate, which is derived from a separate survey, declined to 4% from 4.1% the prior month. Economists expected ...

In the fourth quarter, Amazon reported spending $27.8 billion on property and equipment, significantly higher than the same ...